May Measurement Month 2019: an analysis of blood pressure screening results from Albania

Gentiana Qirjako, Genc Burazeri(University of Medicine Tirana), Iris Mone(University of Medicine Tirana), Rudina Çumashi(University of Medicine Tirana), Xheladin Draçini(University of Medicine Tirana), Albana Fico, Neil R Poulter(Imperial College London), Enver Roshi, Alban Ylli(University of Medicine Tirana), Xin Xia(Imperial College London), Thomas Beaney(Imperial College London)
European Heart Journal Supplements
May 1, 2021
10.1093/eurheartj/suab015
Cited by 1

Related Papers

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k